Antex Biologics Inc.

According to the Antex Biologics Inc. web site: "Effective May 31st 2003, the assets of Antex Biologics Inc. and Antex Pharma Inc. have been acquired by BioPort Corporation."

According to www.wolfaxelrod.com, Antex Biologics "and its wholly owned subsidiary, AntexPharma, is a biopharmaceutical company committed to developing and marketing new products to prevent and treat infections and related diseases. The Company maintains strategic alliances with GlaxoSmithKline, Aventis Pasteur, and the US Department of Defense. The Company currently has two products in human clinical trials and expects to have three additional products in clinical trials within the next six months. Based on the Company's operating cash requirements expected for the remainder of 2002, including costs for clinical trials, the Company will require additional funding."

See www.wolfaxelrod.com for recent press releases.

Contact

Kim Brennen Root
BioPort Corporation
3500 N. Martin Luther King Jr. Blvd
Lansing, MI 48906
517-327-1543

For more information about Antex, contact:
Vic Esposito or Kyle Keese
300 Professional Drive
Gaithersburg, MD 20879
301-590-0129